The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
28
No.
5
May 27, 2005
- Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer
- Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds
- Dietary Interventions Reduce Breast Cancer Risk In Trials
- Novel Treatment Modalities Tested Against Bladder Cancer
- Center And Cooperative Group Clinical Trials Approved By NCI
TCL
Vol.
31
No.
23
June 10, 2005
- Report calls for stronger peer review, prioritization for cancer clinical trials.
- GI Intergroup called a model for proposed scientific steering committees.
- Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.
- Investigation finds no evidence FDA’s Crawford had affair with subordinate.
TCL
Vol.
31
No.
25
June 24, 2005
- Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.
- FDA orders “limited distribution” for lung cancer drug Iressa.
- House approves $210 million for Dept. of Defense cancer research programs.
- House Committee on Appropriations approves $28.5 billion for NIH.
- House panel investigating NIH handling of tissue specimens.
CCL
Vol.
28
No.
6
June 24, 2005
- Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer
- Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer
- Irinotecan And Carboplatin Improve Response In NSCLC
- Enzastaurin Shows Activity In Recurrent High-Grade Glioma
- Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer
- Gemcitabine Improves DFS In Resected Pancreatic Cancer
- Rosenberg: Immunotherapy May Have Broad Potential
- NCI-Approved Clinical Trials
TCL
Vol.
31
No.
26
July 01, 2005
- House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.
- Also in this 8-page issue: Amendment strips funding from two NIHM grants. NCI will commit $7 million to begin restructuring its clinical trials system, Institute director says.
- IOM appoints 22 to National Cancer Policy Forum.
TCL
Vol.
31
No.
27
July 08, 2005
- Advisors approve NCI’s revised plan for $104-million proteomics research program.
- Also in this 8-page issue: Vitamin E doesn’t prevent heart events, cancer, Women’s Health Study finds.
- FDA says green tea unlikely to prevent cancer.
- President’s Cancer Panel annual report finds barriers in translational research stall progress.